Compare Abbott Laboratories (ABT) vs Amazon.com Inc (AMZN) Price & Performance

Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.

The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.

Amazon (AMZN) trades at $240.88, down 1.34% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamental performance with 2025 revenue reaching $716.92 billion and net income of $77.67 billion, representing a 10.83% margin. Recent Q1 2026 earnings beat expectations at $2.78 EPS versus $1.63 expected. Operating cash flow remains strong at $139.51 billion, though heavy investment spending creates negative investing cash flow.

Amazon presents a compelling investment case with strong revenue growth, expanding profitability, and dominant market positions in e-commerce and cloud computing. The primary risks include intense competition in retail and cloud services, significant capital expenditure requirements, and potential regulatory scrutiny. With 88% analyst buy ratings and a $321.11 consensus price target representing 33% upside, Wall Street remains bullish on Amazon's long-term prospects despite near-term valuation concerns.